Aug. 30, 2022 Updated
Review [Eng]
  1. A. Figueiras, C. Domingues, I. Jarak, A. I. Santos, A. Parra, A. Pais, C. A.-Lorenzo, A. Concheiro, A. Kabanov, H. Cabral, F. Veiga, New advances in biomedical application of polymeric micelles. Pharmaceutics 14(8) 1700 (DOI: 10.3390/pharmaceutics14081700) (2022)
  2. M. Skwarczynski, S. Bashiri, Y. Yuan, Z. M. Ziora, O. Nabil, K. Masuda, M. Khongkow, N. Rimsueb, H. Cabral, U. Ruktanonchai, M. A. T. Blaskovich, I. Toth, Antimicrobial activity enhancers: Towards smart delivery of antimicrobial agents. Antibiotics 11 (3) 412 (2022) (DOI: 10.3390/antibiotics11030412)
  3. S. Quader, K. Kataoka, H. Cabral, Nanomedicine for brain cancer. Adv. Drug Deliv. Rev. 182 114115 (2022) (DOI: 10.1016/j.addr.2022.114115)
  4. J. D. Martin, T. Miyazaki, H. Cabral, Remodeling tumor microenvironment with nanomedicines. WIREs Nanomed Nanobiotechnol. 13(6) e1730 (2021) (DOI: 10.1002/wnan.1730)
  5. T. Khan, H. Cabral, Abnormal glycosylation of cancer stem cells and targeting strategies. Front. Oncol. 11 649338 (2021) (DOI:10.3389/fonc.2021.649338)
  6. P. Mi, K. Miyata, K. Kataoka, H. Cabral, Clinical translation of self-assembled cancer nanomedicines. Adv. Therap. 4 Issue 1 2000159 (2021) (DOI: 10.1002/adtp.202000159)
  7. H. Cabral, H. Kinoh, K. Kataoka, Tumor-targeted nanomedicine for immunotherapy. Acc. Chem. Res. 53 Issue 12 2765-2776 (2020) (DOI: 10.1021/acs.accounts.0c00518)
    Supplementary Cover
  8. S. Uchida, F. Perche, C. Pichon, H. Cabral, Nanomedicine-based approaches for mRNA delivery. Mol. Pharmaceutics 17 Issue 10 3654-3684 (2020) (DOI: 10.1021/acs.molpharmaceut.0c00618)
  9. H. Cabral, K. Kataoka, Erythrocyte depletion lifts nanoparticle half-lives. Nature Biomed. Eng. 4 670-671 (2020) (DOI: 10.1038/s41551-020-0586-x)
  10. S. Tanabe, S. Quader, H. Cabral, R. Ono, Interplay of EMT and CSC in cancer and the potential therapeutic strategies. Front. Pharmacol. 11 904 (2020) (DOI: 10.3389/fphar.2020.00904)
  11. J. D. Martin, H. Cabral, T. Stylianopoulos, R. K. Jain, Improving cancer immunotherapy using nanomedicines: Progress, opportunities and challenges. Nat. Rev. Clin. Oncol. 17 Issue4 251-266 (2020) (DOI: 10.1038/s41571-019-0308-z)
  12. P. Mi, H. Cabral, K. Kataoka, Ligand-installed nanocarriers towards precision therapy. Adv. Mater. 32 Issue13 1902604 (2020) (DOI: 10.1002/adma.201902604)
  13. A. B. C. S.-Valle, G. R. R. Souza, C. Q. Paes, T. Miyazaki, A. H. Silva, M. J. Altube, M. J. Morilla, E. L. Romero, T. B. C.-Pasa, H. Cabral, F. Pittella, Nanomedicine strategies for addressing major needs in neglected tropical diseases. Annu. Rev. Control 48 423-441 (2019) (DOI: 10.1016/j.arcontrol.2019.08.001)
  14. S. Uchida, K. Kataoka, Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA. J. Biomed. Mater. Res. A 107 Issue5 978-990 (2019) (DOI: 10.1002/jbm.a.36614)
  15. H. Cabral, K. Miyata, K. Osada, K. Kataoka, Block copolymer micelles in nanomedicine applications. Chem. Rev. 118 (14) 6844-6892 (2018) (DOI: 10.1021/acs.chemrev.8b00199)
  16. Y. Mochida, H. Cabral, K. Kataoka, Polymeric micelles for targeted tumor therapy of platinum anticancer drugs. Expert Opin. Drug Deliv. 14 12 1423-1438 (2017) (DOI: 10.1080/17425247.2017.1307338)
  17. P. Mi, F. Wang, N. Nishiyama, H. Cabral, Molecular cancer imaging with polymeric nanoassemblies: From tumor detection to theranostics. Macromol. Biosc. 17 Issue 1 1600305 (2017) (DOI: 10.1002/mabi.201600305)
  18. H. Cabral, K. Kataoka, 22. The impact of "Development of the polymer micelles carrier system for doxorubicin" on the nanomedicine realm: Original Research Article: Development of the polymer micelle carrier system for doxorubicin, 2001. J. Control. Release 190 70-72 (2014) (DOI: 10.1016/j.jconrel.2014.07.034)
  19. H. Cabral, K. Kataoka, Progress of drug-loaded polymeric micelles into clinical studies. J. Control. Release 190 465-476 (2014) (DOI: 10.1016/j.jconrel.2014.06.042)
  20. H. Cabral, K. Miyata, A. Kishimura, Nanodevices for studying nano-pathophysiology. Adv. Drug Deliv. Rev. 74 35-52 (2014) (DOI: 10.1016/j.addr.2014.06.003)
  21. K. M. Bennett, J. Jo, H. Cabral, B. Rumiana, I. Aoki, MR Imaging techniques for nano-pathophysiology. Adv. Drug Deliv. Rev. 74 75-94 (2014) (DOI: 10.1016/j.addr.2014.04.007)
  22. H. Cabral, K. Kataoka, Bridging polymer science and medicine through supramolecular nanoassemblies. Adv. Polym. Sci. (Hierarchical Macromolecular Structures: 60 Years after the Staudinger Nobel Prize I) 261 249-262 (2013) (DOI: 10.1007/12_2013_271)
  23. H. Cabral, N. Nishiyama, K. Kataoka, Supramolecular nanodevices: From design validation to theranostic nanomedicine. Acc. Chem. Res. 44 (10) 999-1008 (2011) (DOI: 10.1021/ar200094a)
  24. H. Cabral, K. Kataoka, Multifunctional nanoassemblies of block copolymers for future cancer therapy. Sci. Technol. Adv. Mater. 11 (1) 014109 (2010) (DOI: 10.1088/1468-6996/11/1/ 014109)
  25. R. Tong, D. A. Christian, L. Tang, H. Cabral, J. R. Baker,Jr., K. Kataoka, D. E. Discher, J. Cheng, Nanopolymeric Therapeutics. MRS Bull. 34 (6) 422-431 (2009) (DOI: 10.1557/mrs2009.118)
Review [Jpn]
  1. T. Nomoto, Y. Matsumoto, K. Toh, R.J. Christie, K. Miyata, M. Oba, H. Cabral, M. Murakami, S. Fukushima, N. Nishiyama, K. Kataoka, Evaluation of the dynamics of drug delivery systems (DDS) using intravital real-time confocal laser scanning microscopy. Yakugaku Zasshi 132 1347-1354 (2012) (DOI: 10.1248/yakushi.12-00234-1)